Follow
Tamás Tornai
Title
Cited by
Cited by
Year
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ...
Journal of hepatology 73 (4), 842-854, 2020
3402020
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ...
Journal of hepatology 74 (5), 1097-1108, 2021
1882021
Rediscovery of the anti-pancreatic antibodies and evaluation of their prognostic value in a prospective clinical cohort of Crohn’s patients: the importance of specific target …
M Papp, N Sipeki, T Tornai, I Altorjay, GL Norman, Z Shums, ...
Journal of Crohn's and Colitis 9 (8), 659-668, 2015
562015
High versus low energy administration in the early phase of acute pancreatitis (GOULASH trial): protocol of a multicentre randomised double-blind clinical trial
K Márta, AN Szabó, D Pécsi, P Varjú, J Bajor, S Gódi, P Sarlós, A Mikó, ...
BMJ open 7 (9), e015874, 2017
522017
High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis
M Papp, N Sipeki, Z Vitalis, T Tornai, I Altorjay, I Tornai, M Udvardy, ...
Journal of hepatology 59 (3), 457-466, 2013
492013
Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis
T Tornai, E Palyu, Z Vitalis, I Tornai, D Tornai, P Antal-Szalmas, ...
World journal of gastroenterology 23 (29), 5412, 2017
482017
Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
NK Gatselis, T Tornai, Z Shums, K Zachou, A Saitis, S Gabeta, R Albesa, ...
World Journal of Gastroenterology 26 (34), 5130, 2020
432020
Deleterious effect of proton pump inhibitors on the disease course of cirrhosis
T Janka, T Tornai, B Borbély, D Tornai, I Altorjay, M Papp, Z Vitális
European journal of gastroenterology & hepatology 32 (2), 257-264, 2020
352020
Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients
G Kovacs, N Sipeki, B Suga, T Tornai, K Fechner, GL Norman, Z Shums, ...
PLoS One 13 (3), e0194166, 2018
302018
Macrophage activation marker, soluble CD 163, is an independent predictor of short‐term mortality in patients with cirrhosis and bacterial infection
T Tornai, Z Vitalis, N Sipeki, T Dinya, D Tornai, P Antal‐Szalmas, ...
Liver International 36 (11), 1628-1638, 2016
302016
Presepsin teardown-pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis
M Papp, T Tornai, Z Vitalis, I Tornai, D Tornai, T Dinya, A Sumegi, ...
World Journal of Gastroenterology 22 (41), 9172, 2016
282016
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis
T Tornai, D Tornai, N Sipeki, I Tornai, R Alsulaimani, K Fechner, ...
Scientific reports 8 (1), 399, 2018
272018
Lectin‐complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections
I Foldi, T Tornai, D Tornai, N Sipeki, Z Vitalis, I Tornai, T Dinya, ...
Liver International 37 (7), 1023-1031, 2017
252017
Major changes of von Willebrand factor multimer distribution in cirrhotic patients with stable disease or acute decompensation
E Palyu, J Harsfalvi, T Tornai, M Papp, M Udvardy, K Szekeres-Csiki, ...
Thrombosis and Haemostasis 118 (08), 1397-1408, 2018
222018
Mucosal autoimmunity to cell-bound GP2 isoforms is a sensitive marker in PSC and associated with the clinical phenotype
M Sowa, R Kolenda, DC Baumgart, J Pratschke, M Papp, T Tornai, ...
Frontiers in Immunology 9, 1959, 2018
142018
Detailed characteristics of post-discharge mortality in acute pancreatitis
D Czapári, A Váradi, N Farkas, G Nyári, K Márta, S Váncsa, R Nagy, ...
Gastroenterology 165 (3), 682-695, 2023
112023
Functional polymorphisms of innate immunity receptors are not risk factors for the non‐SBP type bacterial infections in cirrhosis
T Dinya, T Tornai, Z Vitalis, I Tornai, B Balogh, D Tornai, P Antal‐Szalmas, ...
Liver International 38 (7), 1242-1252, 2018
112018
Intestinal fatty acid binding protein: marker of enterocyte damage in acute and chronic gastroenterological diseases
D Kocsis, M Papp, T Tornai, Z Tulassay, L Herszényi, M Tóth, M Juhász
Orvosi Hetilap 157 (2), 59-64, 2016
112016
Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosis
RA Moran, C Halloran, Q Guo, C Umapathy, NY Jalaly, S Jain, D Cowzer, ...
Pancreatology 22 (1), 67-73, 2022
92022
Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study
D Tornai, P Antal-Szalmas, T Tornai, M Papp, I Tornai, N Sipeki, T Janka, ...
BMC gastroenterology 21, 1-13, 2021
92021
The system can't perform the operation now. Try again later.
Articles 1–20